calpain inhibitor 2 has been researched along with calcimycin in 2 studies
Studies (calpain inhibitor 2) | Trials (calpain inhibitor 2) | Recent Studies (post-2010) (calpain inhibitor 2) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
---|---|---|---|---|---|
68 | 0 | 13 | 11,946 | 40 | 444 |
Protein | Taxonomy | calpain inhibitor 2 (IC50) | calcimycin (IC50) |
---|---|---|---|
XBP1 | Homo sapiens (human) | 1.41 | |
DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anyane-Yeboa, K; Chan, SO; Chiu, FC; Ko, L; Runko, E | 1 |
Bebawy, M; Luk, F; Roseblade, A; Ung, A | 1 |
2 other study(ies) available for calpain inhibitor 2 and calcimycin
Article | Year |
---|---|
Calcium ionophore-induced degradation of neurofilament and cell death in MSN neuroblastoma cells.
Topics: Calcimycin; Calpain; Carrier Proteins; Cell Death; HSC70 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Intermediate Filament Proteins; Leupeptins; Nerve Tissue Proteins; Neuroblastoma; Neurofibrils; Oligopeptides; Tumor Cells, Cultured | 1998 |
Targeting microparticle biogenesis: a novel approach to the circumvention of cancer multidrug resistance.
Topics: Acrylates; Amides; Antineoplastic Agents; Breast Neoplasms; Calcimycin; Cell Line, Tumor; Cell-Derived Microparticles; Cystamine; Cysteamine; Drug Resistance, Neoplasm; Female; Humans; Molecular Targeted Therapy; Oligopeptides; Pantetheine; Pyridines; Verapamil | 2015 |